Streptococcus suis is a bacterium commonly carried in the respiratory tract that is also 25 one of the most important invasive pathogens of swine, commonly causing meningitis, arthritis, 26 and septicemia. Due to the existence of many serotypes and a wide range of immune evasion 27 capabilities efficacious vaccines are not readily available. The selection of S. suis protein 28
Introduction 40
Streptococcus suis is a Gram-positive bacterium commonly carried in the tonsil and nasal 41 cavity of swine that can cause systemic disease and secondary pneumonia, especially in young 42 pigs. Streptococcal disease is widespread wherever pig production occurs and systemic invasion 43 most commonly results in septicemia, meningitis, arthritis, and/or polyserositis causing 44 significant economic losses to the industry. S. suis is also a zoonotic agent capable of causing 45 SSU1355 was identified as a putative surface-anchored 5'-nucleotidase, a hydrolytic 208 enzyme that catalyzes the hydrolysis of a nucleotide into a nucleoside and a phosphate. These 209 enzymes have been identified as virulence factors, purportedly by hydrolyzing extracellular 210 nucleotides for purine salvage, degrading nucleotide diphosphate sugars that can then be used by 211 the cell, and/or by generating extracellular adenosine in the host, which is a powerful 212 immunosuppressant signaling molecule. Staphylococcus aureus produces extracellular adenosine 213 to evade clearance by the host immune system, an activity attributed to the 5'-nucleotidase 214 activity of adenosine synthase (AdsA) (29) . 215 SSU1215 was identified as a putative surface-anchored dipeptidase. These enzymes play 216 roles in several physiologic processes, such as catabolism of exogenously supplied peptides and 217 the final steps of protein turnover. 218 SS1773 was identified as a putative surface-anchored serine protease. Prokaryotic serine 219 proteases have roles in several physiological processes, such as those associated with 220 metabolism, cell signaling, and defense response and development; however, functional 221 associations for a large number of prokaryotic serine proteases are relatively unknown. 222
Since the methods used to identify these proteins indicated they were involved in 223 respiratory colonization fitness, there was the possibility that locally induced mucosal or 224 parenterally induced systemic immune responses, or both, would be important for protection. 225
Since raising CDCD pigs is not a trivial matter and S. suis infection can have severe clinical 226 consequences, it was decided to vaccinate with all five proteins by both routes to enhance the 227 potential for success using the fewest number of pigs initially. shown to induce enhanced immune responses compared to some commonly used adjuvants (33) . 239
Both the magnitude of the systemic immune response and degree of protection was dependent on 240 the parenteral adjuvant administered with the proteins. This would suggest that parenteral 241 vaccination was the important delivery method for protection; however, a role for mucosal 242 immunization in protection or priming of the immune response cannot be ruled out, and 243 additional studies separating the routes of administration will be needed to determine these roles. 244
Even though the proteins were identified as potentially contributing to fitness for 245 respiratory colonization, all surviving vaccinated animals showed tonsil and nasal colonization 246 by the challenge organism. A quantitative comparison of colonizing bacterial load for 247 immunized versus non-immunized animals was beyond the scope of this preliminary study, so 248 there could have been a reduction of numbers of S. suis colonizing the respiratory sites that was 249 not detected. In addition, since mucosal IgA was not measured it is difficult to state whether 250 there was a failure of induction of mucosal antibodies to these proteins or a failure of antibodies 251 on January 24, 2018 by Royal Veterinary College http://iai.asm.org/ Downloaded from 12 to prevent colonization. The impact of immunization on reduction of colonization load by 252 pneumococcus in a mouse model was found to be dependent on individual host as well vaccine 253 associated factors (34). There was a reduction of systemic disease in vaccinated animals, which 254 could be due to reduced colonization and invasion or an increase in bactericidal/opsonic 255 antibodies, or both. Streptococcus suis was also isolated from the spleen of two apparently 256 healthy vaccinated pigs. These animals probably had an ongoing bacteremia that was being 257 controlled and cleared by the immune response since, as indicated, the animals showed no 258 antemortem, post mortem or histopathological signs of streptococcal disease. It is possible that 259 this represented a very recent bacteremia; however, in our infection model with this strain of S. 260 suis, we rarely have pigs develop or succumb to disease past day 10 of exposure. 261
Peripheral IFN-γ recall responses were evaluated at various time points after vaccination, 262
and there was a reduction in the number of peripheral S. suis-specific IFN-γ SC after the boost 263 (Figure 3 ). However, there was an increase in peripheral S. suis-specific IgG levels after the 264 second dose of vaccine, indicating a boost in immune responses following the second dosing. 265
While the reduction in IFN-γ SC was somewhat unexpected, it is important to note that IFN-γ SC 266 serve as a single measure of immune cell activation, and cell-mediated immune responses after 267 prime-boost were likely skewed towards T-helper responses not involving IFN-γ production. 268
Given the increased levels of S. suis-specific IgG after the boost, T cell responses were likely 269 directed towards B-cell affinity maturation and plasma cell generation, which would include 270 production of IL-13 and IL-5, though levels of these cytokines were not measured in this study. The five proteins identified are highly conserved and present in almost all strains of S. 284 suis tested including probable non-virulent strains. Since these strains are normal colonizers of 285 pigs, one might expect that antibodies against these proteins are already present in pigs on farm. 286
There was reactivity to four of the proteins in serum collected from a convalescent pig infected 287 with virulent S. suis ( Figure 1) ; however, non-virulent strains are commensal microbes that could 288 colonize without triggering a significant immune response. The diversity of antibody responses 289 to these proteins in pigs naturally exposed to S. suis, with or without disease, might shed further 290 light on their respective contribution to immune protection. Further studies will also be needed to 291 evaluate the optimum approach to field application of these subunits as protective immunogens, 292 including the potential for sow versus piglet immunization and the possibility of prior passive or 293 active antibody interference. In addition, the reactivity of the sera from vaccinated pigs against 294 several diverse S. suis strains commonly associated with disease in pigs may indicate a potential 295 for cross-protection that will have to be confirmed through further challenge studies. The primers used in this study are listed in Table 6 . The primers were designed using 333 Primer3web version 4.0.0 (http://primer3.ut.ee) and synthesized by Sigma-Aldrich Ltd. The 334 primers were rehydrated with deionized water to a concentration of 100 µM on arrival and 335 working stocks of 10 µM concentration were prepared. All primers were stored at -20 o C. 336
The PCR products and DNA samples were analyzed by agarose gel electrophoresis. The 337 agarose gels were visualized and photographed using the Gel Doc™ XR+ imaging system with 338
Image Lab™ image acquisition and analysis software (Bio-Rad Laboratories Ltd.). 339 SDS-PAGE analyses were performed with whole cell lysates or purified proteins. Samples 340 were diluted in equal volumes of 2X SDS sample buffer, heated at 70 o C for 10 minutes and run 341 carrying the recombinant plasmids were used to inoculate fresh 1-6 L 2YT broth and grown to 369 OD 595nm 0.6 at 37 °C in broth supplemented with 100 µg/ml kanamycin, then induced with 1mM 370 IPTG (isopropyl β-D-1-thiogalactopyranoside, Sigma) at 37 o C for 2, 4 and 24 hours. Protein 371 expression was checked by SDS-PAGE using whole cell lysates. 372
Purification of recombinant vaccine proteins. Recombinant proteins were purified 373 from 1-6 L cultures grown in 2YT broth and induced with 1 mM IPTG for 2 to 4 hours. Cell 374 pellets were washed once in PBS and centrifuged at 3,000 × g for 15 minutes. The cell pellets 375 were resuspended in binding buffer (10 mM imidazole, 300 mM NaCl, 50 mM phosphate, 376 pH:8.0) and sonicated on ice for 6 minutes. Appropriate amounts of Benzonase and rLysozyme 377 (Novagen, Merck Millipore) were added to reduce the viscosity of the lysate and improve protein 378 extraction efficiency. The lysates were first centrifuged at 3,000 × g for 10 minutes at 4 °C to 379 pellet debris and the supernatants were subjected to further centrifugation at 75,000 × g for 1.5 380 hours at 4 °C. Recombinant proteins were subjected to purifications by nickel His-Tag affinity 381 chromatography, anion exchange chromatography, CHAP chromatography and gel filtration 382 when appropriate. Target proteins were confirmed by peptide mass fingerprinting. Protein 383 concentration was determined using spectrophotometry and purified proteins were stored at -80 384
°C. 385
Immunoreactivity of the recombinant proteins with convalescent pig sera. 386
Immunoreactivity against the purified recombinant proteins was tested using serum from a 387 conventionally-reared pig experimentally infected with S. suis serotype 2. Naïve sera for a 388 Caesarean-derived, colostrum-deprived (CDCD) pigs were distributed into groups as follows 405 (Table 3) (v/v) mix; groups 3 and 4 were control groups given PBS mixed with the same adjuvants given 413 to groups 1 and 2 respectively (3 pigs each); and group 5 was given PBS only (4 pigs). Pigs 414 received a booster dose of the same respective formulation 2 weeks after priming, and 2 weeks 415 after the boost pigs were challenged with 2 ml of 10 9 CFU/ml S. suis P1/7 IN (1 ml per nare). buffer (pH 9.6) overnight at 4 °C at the following concentrations: SSU1773 (1 µg/ml), SSU1355 435 (2 µg/ml), SSU1915 (1 µg/ml), SSU0185 (1 µg/ml), SSU1215 (0.5 µg/ml). The next day, plates 436 were blocked with 0.2 ml of blocking buffer [2% BSA in PBS tween (0.05% Tween-20; PBS-T)] 437 for 2 hours at RT and then washed three times with PBS-T. Eleven, two-fold serial dilutions of 438 serum (starting at 1:2000) collected from each pig were made in 1% BSA/PBS-T, transferred to 439 the ELISA plate in duplicate and incubated at RT for 2 hours. Plates were washed and S. suis 440 specific IgG detected by adding 0.1 ml of anti-porcine IgG conjugated to horseradish peroxidase 441 (KPL, catalog 14-14-06, dilution 1:10,000) and incubating at RT for 1 hour. Plates were washed 442
and TMB substrate added according to manufacturer's recommendations (Life Technologies). 443
After 15 minutes with substrate, 0.05 ml of stop solution (2N H 2 SO 4 ) was added and optical 444 density read at 450 nm with correction at 655 nm. The resulting OD data were modeled as a 445 nonlinear function of the Log 10 dilution using Graph Pad Prism (La Jolla, CA) log (agonist) vs. 446 response-variable slope four-parameter logistic model. Endpoints were interpolated by using 4X 447 the average OD of the day 0 sample of each respective pig serum as the cutoff. 448
To determine whether serum IgG reacted with whole P1/7 S. suis bacteria, heat-449 inactivated (HI) P1/7 was used as antigen in an indirect ELISA. To make antigen, a single P1/7 450 colony was inoculated into 5 ml THB and incubated at 37 °C in 5% CO 2 at 200 rpm for 451 approximately 6 hours, at which time it had reached an OD=0.6 at Abs600. The bacteria were 452 centrifuged at 4000 x g to pellet, media decanted and bacteria resuspended in 5 ml PBS. Bacteria 453 were heat-inactivated (HI) by incubating the suspension in a water bath at 85 °C for 20 minutes. Inactivation was confirmed by plating 0.1 ml of the heat-inactivated preparation on blood agar 455 plates and incubating the plates at 37 °C in 5% CO 2 . No growth was observed on the plate after 2 456 days. Aliquots were stored frozen at -80 °C. Protein concentration of the HI P1/7 was determined 457 on January 24, 2018 by Royal Veterinary College http://iai.asm.org/ Downloaded from using BCA protein microtiter assay according to manufacturer's recommendations (Pierce). 458
Immulon-2 plates were coated with 0.1 ml of 7.5 µg/ml of HI P1/7 diluted in 100 mM carbonate-459 bicarbonate buffer (pH 9.6). Serum samples collected on day 0 and day 28 from each pig were 460 diluted 1:500 and used in the assay. P1/7-specific IgG was detected and the ELISA completed as 461 described above for individual proteins. Data is reported as the OD at 450 nm with correction at 462 655 nm. A checkerboard of HI P1/7 concentrations and a pool of sera from day 0 and day 28 was 463 used to determine optimal ELISA conditions (data not shown). Similar techniques were used to 464 evaluate IgG reactivity with a collection of other HI S. suis strains comprised of two randomly 465 selected representatives of those serotypes most commonly associated with disease (1, 2, 1/2, 3 466 and 14) (see Table 1 ), with bacteria reaching OD's of 0.6 -1.1 at 600 nm in the 6-8 hour culture 467 period prior to HI (data not shown) and all HI S. suis coated at 7.5 g/ml for the ELISA. Cytokines produced by PBMCs collected on day 28 following restimulation with the 483 protein pool were also measured. PBMC culture supernatants were collected 72 hours after 484 restimulation with the protein pool or media-only and used to evaluate cytokine levels secreted 485 by the cells. The amount of IFN-γ, TNF-α, IL-2, and IL-10 in the media was determined by 486 multiplex cytokine ELISA according to manufacturer's recommendations using provided 487 recombinant proteins as standards to determine concentrations in the supernatants (Aushon 488
Biosystems) 489
Statistical Analysis. Survival analysis was performed using the product limit method of 490
Kaplan and Meier, and comparing survival curves using the logrank test (GraphPad Prism, La 491 Jolla, CA). Antibody titers were Log10 converted and a two-tailed student's t-test was used to 492 evaluate statistical differences between groups 1 and 2 for indicated comparisons, with a p-value 493 <0.05 considered significant. One-way analysis of variance (ANOVA) with a Tukey's multiple 494 comparison post-test was performed to evaluate statistical differences between groups (p<0.05) 495 for the number of IFN- secreting cells and cytokine production. Graph Prism software (version 496 6.0) was used for statistical analysis. candidate proteins were expressed in E. coli and purified as described in the Materials and 715
Methods. The purified proteins were run on SDS-PAGE (A) and also transferred to membranes 716 and probed with either serum from a pig experimentally infected with S. suis serotype 2 (B) or 717 sera from pigs raised in a pathogen free environment as a negative control (C). 
